Zynex, Inc. (OTCMKTS:ZYXI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02
Appointment of Giuseppe Papandrea as Chief Operating Officer
Effective July 22, 2019, the Board of Directors appointed Giuseppe Papandrea as Chief Operating Officer of Zynex, Inc. (the “Company”). Additionally, on such date, the Company entered into an employment agreement with Mr. Papandrea, as described below.
Giuseppe Papandrea served as Vice President of Operations at Arrow Electronics, a global provider of electronic components and enterprise computing solutions from December 2016 to July 2019. In this capacity he utilized his global background, breadth of organizational functional knowledge, and analogous vertical experience to help customers in Security, Healthcare and Medical, Technology and Media scale rapidly (e.g. +25% quarter on quarter growth). From January 2003 through July 2016, Mr. Papandrea worked for Orica USA, Inc. in Australia, Singapore, Germany, the UK, Chile and the USA in a variety of senior leadership roles driving scale, and transformation across industries including; Resources, Energy, Technology, Industrial, Transportation, and Retail .
Mr. Papandrea holds a Bachelor of Commerce, (minor in Accounting and Law) from the University of Western Sydney in Australia and has undertaken Business Administration Leadership and Management development through INSEAD, and Korn Ferry.
There is no arrangement or understanding between Mr. Papandrea and any other person to which he was selected as an officer of the Company. There is no family relationship between Mr. Papandrea and any director or executive officer of the Company, and Mr. Papandrea is not a party to a related party transaction within the meaning of Item 404(a) of Regulation S-K.
to Mr. Papandrea’s employment agreement, the Company and Mr. Papandrea agreed to the following:
d) Exhibits. The following exhibits are filed with this report.
| 10.1 | Employment Agreement effective July 22, 2019, entered into between Zynex, Inc. and Giuseppe Papandrea |
| 99.1 | Press Release |
ZYNEX INC Exhibit
EX-10.1 2 tv525745_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into effective June 13th,…
To view the full exhibit click here
About Zynex, Inc. (OTCMKTS:ZYXI)
Zynex, Inc. operates through the Electrotherapy and Pain Management Products segment. The Company conducts its business through its subsidiaries and the operating subsidiary is Zynex Medical, Inc. (ZMI). Its other subsidiaries include Zynex Monitoring Solutions, Inc. (ZMS) and Zynex Europe, ApS (ZEU). ZMI designs, manufactures and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. ZMS is in the process of developing its blood volume monitoring product for non-invasive cardiac monitoring. ZEU intends to focus on sales and marketing its products within the international marketplace, upon receipt of necessary regulatory approvals. It markets and sells Zynex-manufactured products and distributes private labeled products. Its products include NexWave, NeuroMove, InWave, Electrodes and Batteries. ZMI devices are intended for pain management to reduce reliance on drugs and medications.
